Jaka jest cena za Prince Pharmaceutical Co., Ltd. (6935)

Cena za Prince Pharmaceutical Co., Ltd. (6935) wynosi $0.89991249

Jaka jest kapitalizacja rynkowa dla Prince Pharmaceutical Co., Ltd. (6935)

Kapitalizacja rynkowa dla Prince Pharmaceutical Co., Ltd. (6935) wynosi $33.67M

Prince Pharmaceutical Co., Ltd. (6935) Marża Operacyjna

Prince Pharmaceutical Co., Ltd. operates in the production and global sale of active pharmaceutical ingredients (APIs), primarily focusing on vitamin B1. Its market presence extends across Taiwan, Japan, Korea, and other international territories. The company's product portfolio also encompasses a variety of consumer health items and general medicines. These offerings include popular formulations such as vitamin C tablets and vitamin B complex tablets, alongside specialized supplements like natto and rhodiola extract capsules, probiotic sachets, and various plant extract capsules. In addition to vitamin B1, Prince Pharmaceutical supplies a comprehensive array of other APIs, notably felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. The company's distribution network specifically includes countries within Spain and the wider European continent. Established in 1962, Prince Pharmaceutical Co., Ltd. is based in Yunlin County, Taiwan.

Rok	Marża operacyjna	Zmień
Za mało danych dla podanych dat.

Rok

Marża operacyjna

Zmień

Za mało danych dla podanych dat.

Firma	Marża operacyjna	Różnica w marży operacyjnej	Kraj
MERCK Kommanditgesellschaft auf Aktien MER.SW	0.00%	-	DE
Merck KGaA MRK.DE	0.00%	-	DE
Takeda Pharmaceutical Company Limited 4502.T	0.00%	-	JP
Galderma Group AG GALD.SW	0.00%	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	22.93%	-	IN

Firma

Marża operacyjna

Różnica w marży operacyjnej

Kraj